PIMCO Investment Grade Corporate Bond Index ETF (CORP) Price

Corcept Therapeutics Plummets 48%, Marking Worst Day in 11 Years

Corcept Therapeutics (CORP) stock plummeted 48% in its worst intraday performance in 11 years, signaling a potential fundamental crisis at the company.